Table 1.
Patient Clinical and Pathological Characteristics.
| Number of patients | 50 |
| Mean Age (years) (SD) | 67 (5.8) |
| Median Pre-op PSA (IQR) | 8.64 (5.89-11.24) |
| Perineural Inv in biopsy (%) | |
| Yes | 5 (5.0) |
| No | 45 (90.0) |
| Median Weight Sp in gr (MIN-MAX) | 49.5 (40-66) |
| Gleason (%) | |
| 6 | 20 (40.0) |
| 7 | 21 (42.0) |
| 8 | 1 (2.0) |
| 9 | 8 (16.0) |
| Surgical Margins (%) | |
| Negative | 40 (80.0) |
| Positive | 10 (20.0) |
| pT stage (%) | |
| pT0 | 1 (2.0) |
| pT2a | 7 (14.0) |
| pT2b | 5 (10.0) |
| pT2c | 22 (44.0) |
| pT3a | 4 (8.0) |
| pT3 b | 11 (22.0) |
| Biochemical Recurrence (%) | |
| No | 28 (56.0) |
| Yes | 22 (44.0) |
| Median PSA (MIN-MAX) | 0.03 (0.01-0.06) |
SD: Standard deviation, PSA: Prostatic Specific Antigen, IQR: interquartile range.